The Board of Directors resolved to hold 2020 Annual General Meeting

The board of directors have resolved not to distribute dividends for 2019

Board of Directors approved the Company’s 2019 financial statement

Clarification on News Article by Economy Daily News

OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Gastric Cancer

OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare Conference

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Pancreatic Cancer

Supplementary statement regarding the news article by Economy Daily News

Board of Directors Agreed Subsidiary OBI Pharma (Shanghai) Limited to Implement Partial Intellectual Property Rights of Headquarter – Rights in China